Search for Clinical Trial Results
Lymphoblastic Lymphoma - 26 Studies Found
Status | Study |
Withdrawn |
Study Name: An Open-Label, Single-Arm, Multicenter Pharmacokinetic Study of Intramuscular Erwinaze® (Asparaginase Erwinia Chrysanthemi)/Erwinase® (Crisantaspase) Condition: Date: 2024-05-18 |
Recruiting |
Study Name: Safety and Efficacy of Isatuximab in Lymphoblastic Leukemia Condition: T-cell Type Acute Leukemia-Precursor T-lymphoblastic Lymphoma/Leukaemia Date: 2016-12-19 Interventions:
|
Completed |
Study Name: A Study of Erwinaze Administered Intravenously in Patients Who Had an Allergy to Frontline Asparaginase Therapy Condition:
Date: 2012-06-25 Interventions: Drug: asparaginase Erwinia chrysanthemi |
Recruiting |
Study Name: Four Drug Reinduction With Bortezomib for Relapsed or Refractory ALL or LL in Children and Young Adults Condition:
Date: 2015-08-04 Interventions:
|
Recruiting |
Study Name: Risk-Adapted Chemotherapy in Treating Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia or Localized B-Lineage Lymphoblastic Lymphoma Condition:
|
RECRUITING |
Study Name: A Study Evaluating the Safety and Efficacy of BEAM-201 in Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia (T-ALL) or T-Cell Lymphoblastic Lymphoma (T-LL) Condition: Lymphoblastic Lymphoma Date: 2024-05-18 Interventions: A single dose of BEAM-201 administered by IV following one of two lymphodepletion regimens |